Search

Your search keyword '"Ihle-Hansen, Hege"' showing total 359 results
Start Over "Ihle-Hansen, Hege"
359 results on '"Ihle-Hansen, Hege"'

51. Efficacy and Safety of Individualized Coaching After Stroke: the LAST Study (Life After Stroke): A Pragmatic Randomized Controlled Trial

Author

Askim, Torunn, Langhammer, Birgitta, Ihle-Hansen, Hege, Gunnes, Mari, Lydersen, Stian, Indredavik, Bent, Engstad, Torgeir, Magnussen, Jon, Hansen, Anne, Schjørlien, Rune, Engen, Stian, Osmundnes, Randi Moxnes, Olerud, Anne-Britt, Knudsen, Camilla, Hansen, Trine, Schroeter, Walburga, Fjelldal, Gro Stensrud, Hovde, Kristin, Reneflot, Kristine Helen, Wennberg, Lisa, Norvang, Ole Petter, Phan, Ailan, Storvoll, John Bjørn, Ørjaset, Brede, Syvertsen, Marianne, Berger, Ingvild, Dahl, Anne Eitrem, Sandø, Christine Lundemo, Kjølstad, Veronica, Hansen, Alexander, Vileid, Helene Kværne, Giddal, Maren Hjelle, Bernhardt, Julie, and Langhorne, Peter

Published
2018
Full Text
View/download PDF

52. Author response for 'No add-on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham-controlled trial combining tDCS with computerized cognitive training'

Author

null Ulrichsen, Kristine M., null Kolskar, Knut K., null Richard, Genevieve, null Pedersen, Mads Lund, null Alnaes, Dag, null Dorum, Erlend S., null Sanders, Anne-Marthe, null Tornas, Sveinung, null Maglanoc, Luigi A., null Engvig, Andreas, null Ihle-Hansen, Hege, null Nordvik, Jan E., and null Westlye, Lars T.

Published
2022
Full Text
View/download PDF

53. Cognitive impairment in people with physical frailty using the phenotype model : A systematic review and meta analysis

Author

Vahedi, Ali, Eriksdotter, Maria, Ihle-Hansen, Hege, Wyller, Torgeir Bruun, Øksengård, Anne Rita, Fure, Brynjar, Vahedi, Ali, Eriksdotter, Maria, Ihle-Hansen, Hege, Wyller, Torgeir Bruun, Øksengård, Anne Rita, and Fure, Brynjar

Abstract

OBJECTIVE: We performed a systematic review and meta-analysis to study the relationship between cognitive functioning and phenotypic frailty status. METHODS: We searched Pubmed, Cochrane Library and Epistemonikos from 2000 until March 2022, and used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Samples included both sexes, age ≥55 years, assessed with standardized measures of the different cognitive domains and the frailty phenotype model and analyzing the relationship between the frailty subtypes pre-frail, frail and robust and specific cognitive function. RESULTS: Eleven studies published from 2008 until March 2022 fulfilled the inclusion criteria, and 10 were included in our meta-analyses. Sample sizes varied from 104 to 4649 individuals. Mean Mini-Mental State Examination (MMSE) scores ranged from 17.0 to 27.6, with mean difference (MD) of -2.55 (95% confidence interval [CI] -3.32, -1.78) in frail compared to robust, MD -1.64 (95% CI -2.21, -1.06) in frail compared to prefrail and MD -0.68 (95% CI -0.94, -0.43) in prefrail compared to robust. In subgroup analyses, frail persons had lower scores in the memory domain with standardized mean difference (SMD) -1.01 (95% CI -1.42, -0.59). CONCLUSION: MMSE scores were significantly lower in frail compared to robust and prefrail persons and in prefrail compared to robust persons. Subgroup analysis of memory revealed significantly poorer scores in frail compared to robust. The results indicate a strong relationship between physical frailty and cognitive impairment suggesting incorporation of cognitive function in frailty assessments.

Published
2022
Full Text
View/download PDF

55. No add‐on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham‐controlled trial combining tDCS with computerized cognitive training

Author

Ulrichsen, Kristine M., primary, Kolskår, Knut K., additional, Richard, Geneviève, additional, Pedersen, Mads Lund, additional, Alnæs, Dag, additional, Dørum, Erlend S., additional, Sanders, Anne‐Marthe, additional, Tornås, Sveinung, additional, Maglanoc, Luigi A., additional, Engvig, Andreas, additional, Ihle‐Hansen, Hege, additional, Nordvik, Jan E., additional, and Westlye, Lars T., additional

Published
2022
Full Text
View/download PDF

58. sj-pdf-1-eso-10.1177_23969873221078136 ��� Supplemental meterial for Pressor therapy in acute ischaemic stroke: an updated systematic review

Author

Str��msnes, Torbj��rn Austveg, Kaugerud Hagen, Truls J��rgen, Ouyang, Menglu, Wang, Xia, Chen, Chen, Rygg, Silje-Emilie, Hewson, David, Lenthall, Rob, McConachie, Norman, Izzath, Wazim, Bath, Philip M, Dhillon, Permesh Singh, Podlasek, Anna, England, Timothy, Sprigg, Nikola, Robinson, Thompson G, Advani, Rajiv, Ihle-Hansen, Hege, Sandset, Else Charlotte, and Krishnan, Kailash

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental meterial, sj-pdf-1-eso-10.1177_23969873221078136 for Pressor therapy in acute ischaemic stroke: an updated systematic review by Torbj��rn Austveg Str��msnes, Truls J��rgen Kaugerud Hagen, Menglu Ouyang, Xia Wang, Chen Chen, Silje-Emilie Rygg, David Hewson FRCA, Rob Lenthall, Norman McConachie, Wazim Izzath, Philip M Bath, Permesh Singh Dhillon, Anna Podlasek, Timothy England, Nikola Sprigg, Thompson G Robinson, Rajiv Advani, Hege Ihle-Hansen, Else Charlotte Sandset and Kailash Krishnan in European Stroke Journal

Published
2022
Full Text
View/download PDF

60. Additional file 4 of Paramedic Norwegian Acute Stroke Prehospital Project (ParaNASPP) study protocol: a stepped wedge randomised trial of stroke screening using the National Institutes of Health Stroke Scale in the ambulance

Author

Bugge, Helge Fagerheim, Guterud, Mona, Bache, Kristi C. G., Braarud, Anne-Cathrine, Eriksen, Erik, Fremstad, Kjell Otto, Ihle-Hansen, Hege, Ingebretsen, Svein H��kon, Kramer-Johansen, Jo, Larsen, Karianne, R��islien, Jo, Thorsen, Kjetil, Toft, Mathias, Sandset, Else Charlotte, and Hov, Maren Ranhoff

Abstract

Additional file 4. National Institutes of Health Stroke Scale (NIHSS) (.pdf)

Published
2022
Full Text
View/download PDF

61. Atrial fibrillation in cryptogenic stroke and TIA patients in the nordic atrial fibrillation and stroke The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results

Author

Ratajczak-Tretel, Barbara, Lambert, Anna Tancin, Al-Ani, R., Arntzen, Kathrine Grønning, Bakkejord, G.K., Bekkeseth, H.M.O., Bjerkeli, Vigdis, Eldøen, Guttorm, Gulsvik, Anne Kristine, Halvorsen, Bente, Høie, G.A., Ihle-Hansen, Håkon, Ihle-Hansen, Hege, Ingebrigtsen, S., Johansen, H, Kremer, C., Krogseth, S.B., Kruuse, C., Kurz, Friedrich Martin Wilhelm, Nakstad, Ingvild, Novotny, Vojtech, Næss, Halvor, Qazi, Rehman Ul-Haq, Rezaj, M.K., Rørholt, Dag Marius Nitschke, Steffensen, Linn Hofsøy, Sømark, Jesper, Tobro, Håkon, Truelsen, T.C., Wassvik, L., Ægidius, K.L., Atar, Dan, and Aamodt, Anne Hege

Abstract

Introduction: Secondary stroke prevention depends on proper identification of the underlying etiology and initiation of optimal treatment after the index event. The aim of the NOR-FIB study was to detect and quantify underlying atrial fibrillation (AF) in patients with cryptogenic stroke (CS) or transient ischaemic attack (TIA) using insertable cardiac monitor (ICM), to optimise secondary prevention, and to test the feasibility of ICM usage for stroke physicians. Patients and methods: Prospective observational international multicenter real-life study of CS and TIA patients monitored for 12 months with ICM (Reveal LINQ) for AF detection. Results: ICM insertion was performed in 91.5% by stroke physicians, within median 9 days after index event. Paroxysmal AF was diagnosed in 74 out of 259 patients (28.6%), detected early after ICM insertion (mean 48 ± 52 days) in 86.5% of patients. AF patients were older (72.6 vs 62.2; p

Published
2022

62. Additional file 3 of Paramedic Norwegian Acute Stroke Prehospital Project (ParaNASPP) study protocol: a stepped wedge randomised trial of stroke screening using the National Institutes of Health Stroke Scale in the ambulance

Author

Bugge, Helge Fagerheim, Guterud, Mona, Bache, Kristi C. G., Braarud, Anne-Cathrine, Eriksen, Erik, Fremstad, Kjell Otto, Ihle-Hansen, Hege, Ingebretsen, Svein H��kon, Kramer-Johansen, Jo, Larsen, Karianne, R��islien, Jo, Thorsen, Kjetil, Toft, Mathias, Sandset, Else Charlotte, and Hov, Maren Ranhoff

Abstract

Additional file 3. Consent form (original version in Norwegian) (.pdf)

Published
2022
Full Text
View/download PDF

63. Additional file 1 of Is Frailty Index a better predictor than pre-stroke modified Rankin Scale for neurocognitive outcomes 3-months post-stroke?

Author

Munthe-Kaas, Ragnhild, Aam, Stina, Saltvedt, Ingvild, Wyller, Torgeir Bruun, Pendlebury, Sarah T., Lydersen, Stian, Hagberg, Guri, Schellhorn, Till, Rostoft, Siri, and Ihle-Hansen, Hege

Abstract

Additional file 1: Table I. Comprehensive Geriatric Assessment-Based Frailty Index. Table II. Cognitive status pre-stroke based on Global Deterioration Scale (GDS) ��� N=595. Table III. Logistic regression analysis with NCD as dependent variable, and Frailty (���cognitive function��� excluded from the frailty index) and mRS as predictors. N = 596.

Published
2022
Full Text
View/download PDF

64. Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database

Author

Efjestad, Anne Sverdrup, Ihle-Hansen, Hege, Hjellvik, Vidar, Engedal, Knut, and Blix, Hege Salvesen

Subjects
Pharmacology, Pharmacology (medical)
Abstract

Background: Drugs commonly prescribed for heart rate control may induce adverse drug reactions in Alzheimer patients treated with acetylcholinesterase inhibitors (AChEIs). We have studied use of drugs with a known risk of Torsades de pointes (TdP) and drugs used to treat behavioral and psychological symptoms of dementia, as well as a combination of drugs with a known risk of TdP and drugs with a known heart rate-lowering effect, before and after initiating treatment with AChEIs.Methods: The study applied data from the Norwegian Prescription Database for the period 2004–2016. Prescriptions of concomitant use of drugs in persistent users of AChEIs was studied in a follow-up period from 4 years before to 2 years after AChEI initiation in men and women of two age groups: 37–80 and 81–88 years.Results: A small number of patients were prescribed haloperidol (∼1.5% The second year after AChEI initiation), digoxin/digitoxin (∼3%), and verapamil (∼1.3%), while a substantial proportion of the patients were prescribed betablockers (∼28%) and citalopram/escitalopram (∼17%). During follow-up, up to 6% of the study population were prescribed both betablockers and citalopram/citalopram in addition to AChEIs, a combination that increased over the follow-up period and was observed most frequently in women in the oldest age group.Conclusions: A large proportion (∼44%) of patients treated with AChEIs were prescribed drugs that could cause bradycardic and prolonged time from the start of the Q wave to the end of the T wave (QT interval). Thus, action should be taken to reduce the combination of drugs with risk of bradycardia and prolonged QT interval. Medication review on a regular basis could be an option as an important risk-reducing intervention.

Published
2022

65. Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR‐FIB) study.

Author

Tancin Lambert, Anna, Ratajczak‐Tretel, Barbara, Al‐Ani, Riadh, Arntzen, Kathrine, Bakkejord, Grete Kristin, Bekkeseth, Hanna Marie Otterholt, Bjerkeli, Vigdis, Eldøen, Guttorm, Gulsvik, Anne Kristine, Halvorsen, Bente, Høie, Gudrun Anette, Ihle‐Hansen, Hege, Ihle‐Hansen, Håkon, Ingebrigtsen, Susanne, Johansen, Henriette, Kremer, Christine, Krogseth, Siv Bohne, Kruuse, Christina, Kurz, Martin, and Nakstad, Ingvild

Subjects
ISCHEMIC stroke, ATRIAL fibrillation, BRAIN natriuretic factor, TRANSIENT ischemic attack, RECEIVER operating characteristic curves
Abstract

Background and purpose: There are currently no biomarkers to select cryptogenic stroke (CS) patients for monitoring with insertable cardiac monitors (ICMs), the most effective tool for diagnosing atrial fibrillation (AF) in CS. The purpose of this study was to assess clinically available biomarkers as predictors of AF. Methods: Eligible CS and cryptogenic transient ischaemic attack patients underwent 12‐month monitoring with ICMs, clinical follow‐up and biomarker sampling. Levels of cardiac and thromboembolic biomarkers, taken within 14 days from symptom onset, were compared between patients diagnosed with AF (n = 74) during monitoring and those without AF (n = 185). Receiver operating characteristic curves were created. Biomarkers reaching area under the receiver operating characteristic curve ≥ 0.7 were dichotomized by finding optimal cut‐off values and were used in logistic regression establishing their predictive value for increased risk of AF in unadjusted and adjusted models. Results: B‐type natriuretic peptide (BNP), N‐terminal pro‐brain natriuretic peptide (NT‐proBNP), creatine kinase, D‐dimer and high‐sensitivity cardiac troponin I and T were significantly higher in the AF than non‐AF group. BNP and NT‐proBNP reached the predefined area under the curve level, 0.755 and 0.725 respectively. Optimal cut‐off values were 33.5 ng/l for BNP and 87 ng/l for NT‐proBNP. Regression analysis showed that NT‐proBNP was a predictor of AF in both unadjusted (odds ratio 7.72, 95% confidence interval 3.16–18.87) and age‐ and sex‐adjusted models (odds ratio 4.82, 95% confidence interval 1.79–12.96). Conclusion: Several clinically established biomarkers were associated with AF. NT‐proBNP performed best as AF predictor and could be used for selecting patients for long‐term monitoring with ICMs. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

67. Pressor therapy in acute ischaemic stroke: an updated systematic review

Author

Strømsnes, Torbjørn Austveg, primary, Kaugerud Hagen, Truls Jørgen, additional, Ouyang, Menglu, additional, Wang, Xia, additional, Chen, Chen, additional, Rygg, Silje-Emilie, additional, Hewson, David, additional, Lenthall, Rob, additional, McConachie, Norman, additional, Izzath, Wazim, additional, Bath, Philip M, additional, Dhillon, Permesh Singh, additional, Podlasek, Anna, additional, England, Timothy, additional, Sprigg, Nikola, additional, Robinson, Thompson G, additional, Advani, Rajiv, additional, Ihle-Hansen, Hege, additional, Sandset, Else Charlotte, additional, and Krishnan, Kailash, additional

Published
2022
Full Text
View/download PDF

74. Paramedic Norwegian Acute Stroke Prehospital Project (ParaNASPP) study protocol: a stepped wedge randomised trial of stroke screening using the National Institutes of Health Stroke Scale in the ambulance

Author

Guterud, Mona Marie, primary, Bugge, Helge Fagerheim, additional, Bache, Kristi CG, additional, Braarud, Anne-Cathrine, additional, Eriksen, Erik, additional, Fremstad, Kjell Otto, additional, Ihle-Hansen, Hege, additional, Ingebretsen, Svein Håkon, additional, Kramer-Johansen, Jo, additional, Larsen, Karianne, additional, Røislien, Jo, additional, Thorsen, Kjetil, additional, Toft, Mathias, additional, Sandset, Else Charlotte, additional, and Hov, Maren Ranhoff, additional

Published
2021
Full Text
View/download PDF

75. Sex differences in the Norwegian Tenecteplase Trial (NOR‐TEST)

Author

Ihle‐Hansen, Håkon, primary, Sandset, Else Charlotte, additional, Ihle‐Hansen, Hege, additional, Hagberg, Guri, additional, Thommessen, Bente, additional, Rønning, Ole Morten, additional, Kvistad, Christopher Elnan, additional, Novotny, Vojtech, additional, Næss, Halvor, additional, Waje‐Andreassen, Ulrike, additional, Thomassen, Lars, additional, and Logallo, Nicola, additional

Published
2021
Full Text
View/download PDF

85. The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment : The Nor-COAST Study

Author

Aam, Stina, Gynnild, Mari Nordbø, Munthe-Kaas, Ragnhild, Saltvedt, Ingvild, Lydersen, Stian, Knapskog, Anne-Brita, Ihle-Hansen, Hege, Ellekjær, Hanne, Eldholm, Rannveig Sakshaug, Fure, Brynjar, Aam, Stina, Gynnild, Mari Nordbø, Munthe-Kaas, Ragnhild, Saltvedt, Ingvild, Lydersen, Stian, Knapskog, Anne-Brita, Ihle-Hansen, Hege, Ellekjær, Hanne, Eldholm, Rannveig Sakshaug, and Fure, Brynjar

Abstract

Introduction: Post-stroke cognitive impairment (PSCI) is common, but evidence on the impact of vascular risk factors is lacking. We explored the association between pre-stroke vascular risk factors and PSCI and studied the course of PSCI. Materials and Methods: Vascular risk factors were collected at baseline in stroke survivors (n = 635). Cognitive assessments of attention, executive function, memory, language, and the Montreal Cognitive Assessment (MoCA) were performed at 3 and/or 18 months post-stroke. Stroke severity was assessed with the National Institutes of Health Stroke Scale (NIHSS). PSCI was measured with global z; MoCA z-score; and z-score of the four assessed cognitive domains. Mixed-effect linear regression was applied with global z, MoCA z-score, and z-scores of the cognitive domains as dependent variables. Independent variables were the vascular risk factors (hypertension, hypercholesterolemia, smoking, diabetes mellitus, atrial fibrillation, coronary heart disease, previous stroke), time, and the interaction between these. The analyses were adjusted for age, education, and sex. There were between 5 and 25% missing data for the variables for PSCI. Results: Mean age was 71.6 years (SD 11.7); 42% were females; and the mean NIHSS score at admittance was 3.8 (SD 4.8). Regardless of vascular risk factors, global z, MoCA, and all the assessed cognitive domains were impaired at 3 and 18 months, with MoCA being the most severely impaired. Atrial fibrillation (AF) was associated with poorer language at 18 months and coronary heart disease (CHD) with poorer MoCA at 18 months (LR =12.80, p = 0.002, and LR = 8.32, p = 0.004, respectively). Previous stroke was associated with poorer global z and attention at 3 and 18 months (LR = 15.46, p < 0.001, and LR = 16.20, p < 0.001). In patients without AF, attention improved from 3 to 18 months, and in patients without CHD, executive function improved from 3 to 18 months (LR = 10.42, p < 0.001, and LR = 9.33, p, Funding Agencies:Norwegian Health AssociationDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, NTNU-Norwegian University of Science and TechnologyLiaison Committee for Education, Research and Innovation in Central Norway

Published
2021
Full Text
View/download PDF

86. Cognitive and emotional symptoms in patients with first-ever mild stroke : The syndrome of hidden impairments

Author

Vlachos, Georgios, Ihle-Hansen, Hege, Wyller, Torgeir Bruun, Braekhus, Anne, Mangset, Margrete, Hamre, Charlotta, Fure, Brynjar, Vlachos, Georgios, Ihle-Hansen, Hege, Wyller, Torgeir Bruun, Braekhus, Anne, Mangset, Margrete, Hamre, Charlotta, and Fure, Brynjar

Abstract

Objective: To evaluate the prevalence of cognitive and emotional impairments one year after first-ever mild stroke in younger patients. Design: Prospective, observational, cohort study. Subjects: A consecutive sample of 117 previously cognitively healthy patients aged 18-70 years with mild stroke (National Institutes of Health Stroke Scale score <= 3) were included in 2 hospitals in Norway during a 2-year period. Methods: At 12-month follow-up, patients were assessed using validated instruments for essential cognitive domains, fatigue, depression, anxiety, apathy and pathological laughter and crying. Results: In total, 78 patients (67%) had difficulty with one or a combination of the cognitive domains psychomotor speed, attention, executive and visuospatial function, and memory. Furthermore, 50 patients (43%) had impairment in either one or a combination of the emotional measures for anxiety, depressive symptoms, fatigue, apathy or emotional lability. A total of 32 patients (28%) had both cognitive and emotional impairments. Only 21 patients (18%) scored within the reference range in all the cognitive and emotional tools. Conclusion: Hidden impairments are common after first-ever mild stroke in younger patients. Stroke physicians should screen for hidden impairments using appropriate tools., Funding Agency:Department of Geriatric Medicine, Oslo University Hospital

Published
2021
Full Text
View/download PDF

87. No effect of tDCS on fatigue and depression in chronic stroke patients: an exploratory randomized sham-controlled trial combining tDCS with computerized cognitive training

Author

Ulrichsen, Kristine M., primary, Kolskår, Knut K., additional, Richard, Geneviève, additional, Pedersen, Mads L., additional, Alnæs, Dag, additional, Dørum, Erlend S., additional, Sanders, Anne-Marthe, additional, Tornås, Sveinung, additional, Maglanoc, Luigi A., additional, Engvig, Andreas, additional, Ihle-Hansen, Hege, additional, Nordvik, Jan E., additional, and Westlye, Lars T., additional

Published
2021
Full Text
View/download PDF

88. Forhåndssamtaler om siste livsfase.

Author

Ihle-Hansen, Hege, Ihle-Hansen, Håkon, Rostoft, Siri, Munkhaugen, John, Westbye, Siri Ferden, Romøren, Maria, LereimSævareid, Trygve Johannes, Brøderud, Linn, BergHermansen, Karin, Larsen, Marie Hamilton, Wahl, Astrid Klopstad, MarcAhmed, and Pedersen, Reidar

Published
2024

91. Associations between Post-Stroke Motor and Cognitive Function: A Cross-Sectional Study

Author

Einstad, Marte Stine, primary, Saltvedt, Ingvild, additional, Lydersen, Stian, additional, Ursin, Marie, additional, Munthe-Kaas, Ragnhild, additional, Ihle-Hansen, Hege, additional, Knapskog, Anne-Brita, additional, Askim, Torunn, additional, Beyer, Mona, additional, Næss, Halvor, additional, Seljeseth, Yngve, additional, Ellekjær, Hanne, additional, and Thingstad, Pernille, additional

Published
2020
Full Text
View/download PDF

92. Reliability, sensitivity, and predictive value of fMRI during multiple object tracking as a marker of cognitive training gain in combination with tDCS in stroke survivors

Author

Kolskår, Knut K., primary, Richard, Geneviève, additional, Alnæs, Dag, additional, Dørum, Erlend S., additional, Sanders, Anne‐Marthe, additional, Ulrichsen, Kristine M., additional, Sánchez, Jennifer Monereo, additional, Ihle‐Hansen, Hege, additional, Nordvik, Jan E., additional, and Westlye, Lars T., additional

Published
2020
Full Text
View/download PDF

93. Brain disconnectivity mapping of post-stroke fatigue

Author

Ulrichsen, Kristine M., primary, Kolskår, Knut K., additional, Richard, Geneviève, additional, Alnæs, Dag, additional, Dørum, Erlend S., additional, Sanders, Anne-Marthe, additional, Tornås, Sveinung, additional, Sánchez, Jennifer Monereo, additional, Engvig, Andreas, additional, Ihle Hansen, Hege, additional, de Schotten, Michel Thiebaut, additional, Nordvik, Jan E., additional, and Westlye, Lars T., additional

Published
2020
Full Text
View/download PDF

94. TVA-based modeling of short-term memory capacity, speed of processing and perceptual threshold in chronic stroke patients undergoing cognitive training: case-control differences, reliability, and associations with cognitive performance

Author

Richard, Geneviève, primary, Petersen, Anders, additional, Ulrichsen, Kristine Moe, additional, Kolskår, Knut K., additional, Alnæs, Dag, additional, Sanders, Anne-Marthe, additional, Dørum, Erlend S., additional, Ihle-Hansen, Hege, additional, Nordvik, Jan E., additional, and Westlye, Lars T., additional

Published
2020
Full Text
View/download PDF

95. STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage: Protocol for a randomised controlled trial

Author

Larsen, Kristin Tveitan, primary, Forfang, Elisabeth, additional, Pennlert, Johanna, additional, Glader, Eva-Lotta, additional, Kruuse, Christina, additional, Wester, Per, additional, Ihle-Hansen, Hege, additional, Carlsson, Maria, additional, Berge, Eivind, additional, Al-Shahi Salman, Rustam, additional, Bruun Wyller, Torgeir, additional, and Rønning, Ole Morten, additional

Published
2020
Full Text
View/download PDF

97. Dissecting the cognitive phenotype of post‐stroke fatigue using computerized assessment and computational modeling of sustained attention

Author

Ulrichsen, Kristine M., primary, Alnæs, Dag, additional, Kolskår, Knut K., additional, Richard, Geneviève, additional, Sanders, Anne‐Marthe, additional, Dørum, Erlend S., additional, Ihle‐Hansen, Hege, additional, Pedersen, Mads L., additional, Tornås, Sveinung, additional, Nordvik, Jan E., additional, and Westlye, Lars T., additional

Published
2020
Full Text
View/download PDF

100. Additional file 1 of No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

Author

Hagberg, Guri, Ihle-Hansen, Hege, Fure, Brynjar, Thommessen, Bente, Ihle-Hansen, Håkon, Øksengård, Anne Rita, Beyer, Mona K., Wyller, Torgeir B., Müller, Ebba Gløersen, Pendlebury, Sarah T., and Selnes, Per

Abstract

Additional file 1 : Table 3. Clinical characteristics, imaging features and CSF Aβ-42 of patients with PET examination

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results